Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more

GREY:CTABF - Post Discussion

Canntab Therapeutics Ltd > Emblem News
View:
Post by Eppy on Jun 20, 2018 12:45pm

Emblem News

Emblem put out a NR this morning concerning a joing venture with a German Pharma.  I am wondering if PILL is part of this?  Does anybody on here have any info on that.  GLTA.
Comment by canaken1 on Jun 20, 2018 1:57pm
No one knows the full details of the merger yet, but it stands to reason that the German medical doctors would like to see standards brought in for prescribing medical cannabis to their patients. The Canntab XR Tablets provide extended release, uniform dosing of cannabis over a period of hours and this is one of the features that is being pushed by Emblem sales. I think we are apart of that deal ...more  
Comment by Tonyde on Jun 21, 2018 12:01am
canaken1, I believe that the deal you are referring to is a formation of a joint venture between Emblem and Acnos Pharma, under the name of Emblem Germany (JV). If that's the case, there is "No Connection" at all to Canntab. Emblem will be selling their products through the German pharmaceutical wholesaler Acnos Pharma. Just a reminder, Emblem has the rights to produce and sell ...more  
Comment by canaken1 on Jun 21, 2018 1:04pm
Tony:- Looking at the brief summary of the October 3, 2017 License Agreement between Canntab & Emblem(EMC), EMC will have the exclusive rights for the sale of the XR tablets in Canada . Where it gets murky for me is,  I do not see any statements that EMC is not allowed to sell the manufactured products internationnaly. Royalty payments on the products sold is stated as being "In the ...more  
Comment by Tonyde on Jun 24, 2018 4:49pm
Canaken1, allow me to start by saying that we do not know exactly what the License Agreement (contact) entails. So let's call this post "speculation" for now! We know that both EMC and Canntab are manufacturers and sellers of the product (mj). Why would Canntab give an open to the world rights (if you allow me to use such a term) when they (Canntab) are able to manufacture and sell ...more  
Comment by canaken1 on Jun 25, 2018 10:22pm
Tony, In the Oct.2017 license agreement, Emblem & CannTab have agreed to collaborate in developing the XR pill at Emblem's expense and branded as Emblem product. Emblem would have exclusive sales rights in Canada but clearly states that Emblem would not have the right to export. ( It was my opinion that if Emblem exports the XR branded products it will have to be with CannTab's full ...more  
Comment by Tonyde on Jun 25, 2018 11:19pm
canaken1, I greatly appreciate the info regarding exportation of the XR tablets. That makes sense. I do own both equities too. There's a lot of speculation about a merger or a buyout (EMC - PILL), mostly on the EMC boards. I hope it will not happen especially between them. They're both great entities with great potential, independently. Thank you. GL.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities